Brexpiprazole (OPC-34712) vs aripiprazole in adults with acute schizophrenia: a multicenter, randomized, open-label, flexible-dose, exploratory study

被引：0
|
作者：
Citrome, L. [1 ]
Ota, A. [2 ]
Nagamizu, K. [2 ]
Perry, P. [3 ]
Weiller, E.
Baker, R. [4 ]
机构：
[1] New York Med Coll, Psychiat & Behav Sci, Suffern, NY USA
[2] Otsuka Pharmaceut Co Ltd, CNS, Tokyo, Japan
[3] Otsuka Pharmaceut Dev & Commercializat Inc, Clin Management, Princeton, NJ USA
[4] Otsuka Pharmaceut Dev & Commercializat Inc, CNS Global Med Affairs, Princeton, NJ USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2015年 / 25卷
关键词：
D O I：
10.1016/S0924-977X(15)30711-2
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.3.d.063
引用
下载
收藏
页码：S516 / S517
页数：2
相关论文
共 50 条
  • [31] A flexible-dose study of paliperidone ER in non-acute patients with schizophrenia previously unsuccessfully treated with aripiprazole
    Schreiner, A.
    Hoeben, D.
    Lahaye, M.
    Tessier, C.
    Naber, D.
    Peuskens, J.
    Vauth, R.
    Jasovic-Gasic, M.
    Rancans, E.
    Didi, R.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 238 - 238
  • [32] A FLEXIBLE-DOSE STUDY OF PALIPERIDONE ER IN NON-ACUTE PATIENTS WITH SCHIZOPHRENIA PREVIOUSLY UNSUCCESSFULLY TREATED WITH ARIPIPRAZOLE
    Schreiner, Andreas
    Hoeben, Dagmar
    Lahaye, Marjolein
    Tessier, Christophe
    Naber, Dieter
    Peuskens, Jozef
    Vauth, Roland
    Gasic, Miroslava Jasovic
    Rancans, Elmars
    Didi, Roy
    SCHIZOPHRENIA RESEARCH, 2010, 117 (2-3) : 499 - 499
  • [33] A Long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Maintenance Treatment in Adults with Schizophrenia
    Forbes, Andy
    Hobart, Mary
    Ouyang, John
    Shi, Lily
    Pfister, Stephanie
    Hakala, Mika
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2018, 21 (05): : 433 - 441
  • [34] A Long-Term Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Maintenance Treatment in Adults With Schizophrenia
    Forbes, Robert
    Hobart, Mary
    Ouyang, John
    Pfister, Stephanie
    Hakala, Mika
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S409 - S410
  • [35] Metabolic effects and diabetes risk of aripiprazole versus standard of care in schizophrenia patients enrolled in a European, multicenter, randomized, open-label study
    Blonde, Lawrence
    L'Italien, Gilbert J.
    Gutterman, Elane M.
    Kan, Hong J.
    Hanssens, Linda
    McQuade, Robert D.
    Carson, William
    Pans, Miranda
    Beuzen, Jean-Noel
    DIABETES, 2006, 55 : A205 - A205
  • [36] Safety and Tolerability of Esreboxetine in Fibromyalgia: Results from an Open-label, Flexible-dose, Phase 3 Extension Study
    Arnold, Lesley M.
    Mease, Philip J.
    Thomas, Zachariah
    Moton, Allen
    Tabuteau, Herriot
    JOURNAL OF PAIN, 2024, 25 (04): : 35 - 35
  • [37] Tolerability of lacosamide rapid dose titration: A randomized, multicenter, prospective, open-label study
    Shin, Yong-Won
    Moon, Jangsup
    Cho, Yong Won
    Kim, Dong Wook
    Hong, Sang Bin
    Kim, Do-Yong
    Chang, Hyeyeon
    Yoon, Seo Hyun
    Yu, Kyung-Sang
    Jang, In-Jin
    Lee, Soon-Tae
    Jung, Keun-Hwa
    Park, Kyung-Il
    Jung, Ki-Young
    Kim, Manho
    Chu, Kon
    Lee, SeungHwan
    Lee, Sang Kun
    EPILEPSY & BEHAVIOR, 2021, 115
  • [38] AN OPEN-LABEL, FLEXIBLE-DOSE STUDY OF PALIPERIDONE EXTENDED RELEASE IN CHINESE PATIENTSWITH FIRST-ONSET PSYCHOSIS
    Si, Tianmei
    Yang, Wang
    Qing, Rui
    QingRong, Tan
    KeRang, Zhang
    SCHIZOPHRENIA RESEARCH, 2014, 153 : S217 - S217
  • [39] An Open-Label, Randomized, Flexible-Dose, Crossover Study to Assess the Comparative Efficacy and Safety of Sildenafil Citrate and Apomorphine Hydrochloride in Men with Erectile Dysfunction
    Giammusso, Bruno
    Colpi, Giovanni M.
    Cormio, Luigi
    Ludovico, Giuseppe
    Soli, Marcello
    Ponchietti, Roberto
    Montorsi, Francesco
    Panzironi, Claudio
    Guastella, Bruno
    UROLOGIA INTERNATIONALIS, 2008, 81 (04) : 409 - 415
  • [40] Acute phase management of schizophrenia with aripiprazole: A 8-week open-label prospective study in korea
    Cho, S.
    Kwon, J. S.
    Youn, T.
    Kang, D. H.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 425 - 426
12345